Nanox Posts $55.5M Q2 Loss, Takes $40.7M Impairment, Cuts 67% of Korea Workforce
NNOX sits 25% above its 52-week low of $0.71.
Summary
Nanox reported Q2 2026 revenue of $4.2 million, up 37% year-over-year, but the quarter was dominated by a $40.7 million impairment charge on its AI intangible assets, driving a GAAP net loss of $55.5 million. The impairment was triggered by the sharp share price decline and reduced revenue forecasts, and it wipes out most of the AI unit's book value. The company also disclosed a 67% workforce reduction in South Korea as part of a restructuring expected to save $2 million annually starting 2027. Cash fell to $31.4 million from $60 million at year-end, and the company continues to raise capital, including $8.5 million post-quarter. A class action lawsuit filed June 12, 2026 adds legal risk. The stock trades near $0.89 with a market cap around $73 million, and the going concern warning from Q1 remains unresolved.
At the time of this announcement, NNOX was trading at $0.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $73.1M. The 52-week trading range was $0.71 to $4.71. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.